检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]暨南大学医学院第一附属医院内科,广东广州510630
出 处:《暨南大学学报(自然科学与医学版)》1999年第4期38-40,共3页Journal of Jinan University(Natural Science & Medicine Edition)
摘 要:目的:研究二尖瓣脱垂( M V P) 合并心律失常的临床特点。方法:对60 例 M V P 患者采用彩色多普勒超声显像仪检查确诊。24 h 动态心电图监测心律失常情况。结果:心律失常发生率884 % ,以室性早搏多见(65 % ) ,其次室上性早搏(40 % ) ,传导阻滞较少见(11 % ) 。结论:大多数 M V P 合并心律失常不必治疗,多数预后较好。但如果症状明显,伴危险因素可给予β- 阻滞剂。 M V P 并二尖瓣关闭不全或伴 T I A 者可使用抗凝治疗。Aim:To explore the clinical characteristics of MVP patient with arrhythmia. Methods: Further study of MVP patient with 24 hour dynamic electrocardiogram shown that most of MVP patients were accomanied with arrthythmia. Results: Incidence of arrthythmia is about 88 4% in which ventricular premature systole consisted of 65%. Next was supraventricular premature systole with incidence of 40%. Cardiac conductance blockage was least common with incidence of 11%. Conclusion: The prognosis is optimistic in most MVP patient with arrhythmia and therapeutic procedures are not necesary. However, in patients with apparent arrhythmia syndromes or with high risk factors, β-receptor blockers therapy is necessarty. Anticoagulant therapy is needed for MVP patients accommpanied with mitral valve incompetence or with TIA.
分 类 号:R542.51[医药卫生—心血管疾病] R541.7[医药卫生—内科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28